Skip to main content

Advertisement

ADVERTISEMENT

News

News
08/29/2023

European Society of Cardiology News

European Society of Cardiology News ...
The focused update recommends an SGLT2 inhibitor (dapagliflozin or empagliflozin) in patients with HFmrEF and HFpEF to reduce the risk of heart failure hospitalization or cardiovascular death.
The focused update recommends an SGLT2 inhibitor (dapagliflozin or empagliflozin) in patients with HFmrEF and HFpEF to reduce the risk of heart failure hospitalization or cardiovascular death.
The focused update recommends an...
08/29/2023
Cath Lab Digest
News
08/29/2023

European Society of Cardiology News

European Society of Cardiology News ...
Amsterdam, Netherlands: The European Society of Cardiology (ESC) Guidelines on cardiomyopathies are published online today in European Heart Journal.1 This is the first international guideline document to include all cardiomyopathy...
Amsterdam, Netherlands: The European Society of Cardiology (ESC) Guidelines on cardiomyopathies are published online today in European Heart Journal.1 This is the first international guideline document to include all cardiomyopathy...
Amsterdam, Netherlands: The...
08/29/2023
Cath Lab Digest
News
08/29/2023

European Society of Cardiology News

European Society of Cardiology News ...
Recommendations for patients with diabetes and existing CVD have been revised following the results of large clinical trials.
Recommendations for patients with diabetes and existing CVD have been revised following the results of large clinical trials.
Recommendations for patients...
08/29/2023
Cath Lab Digest

Advertisement

News
08/29/2023

European Society of Cardiology News

European Society of Cardiology News ...
In this study, middle-aged adults with metabolic syndrome had a heart attack or stroke 2.3 years earlier than those without the collection of unhealthy traits.
In this study, middle-aged adults with metabolic syndrome had a heart attack or stroke 2.3 years earlier than those without the collection of unhealthy traits.
In this study, middle-aged...
08/29/2023
Cath Lab Digest
News
08/28/2023

HeartFlow News

HeartFlow News
FFRCT (CCTA-derived Fractional Flow Reserve) is part of a clinical pathway for evaluation and diagnosis of coronary artery disease (CAD) that provides clear insight into a patient’s condition with a patient-specific visual model of the...
FFRCT (CCTA-derived Fractional Flow Reserve) is part of a clinical pathway for evaluation and diagnosis of coronary artery disease (CAD) that provides clear insight into a patient’s condition with a patient-specific visual model of the...
FFRCT (CCTA-derived Fractional...
08/28/2023
Cath Lab Digest
News
08/28/2023

CRF/TCT News

CRF/TCT News
NEW YORK – The Cardiovascular Research Foundation (CRF) has announced the TCT 2023 late-breaking clinical trials. TCT is the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional...
NEW YORK – The Cardiovascular Research Foundation (CRF) has announced the TCT 2023 late-breaking clinical trials. TCT is the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional...
NEW YORK – The Cardiovascular...
08/28/2023
Cath Lab Digest

Advertisement

News
08/28/2023

Cedars-Sinai News

Cedars-Sinai News
The study, led by sudden cardiac arrest expert Sumeet Chugh, MD, found that 50% of individuals who experienced a sudden cardiac arrest also experienced a telling symptom 24 hours before their loss of heart function.
The study, led by sudden cardiac arrest expert Sumeet Chugh, MD, found that 50% of individuals who experienced a sudden cardiac arrest also experienced a telling symptom 24 hours before their loss of heart function.
The study, led by sudden cardiac...
08/28/2023
Cath Lab Digest
News
08/28/2023

Amgen News

Amgen News
The OCEAN(a)-DOSE trial is a multicenter, randomized, double-blind, placebo-controlled dose-finding Phase 2 study in 281 patients with ASCVD and Lp(a) >150 nmol/L.
The OCEAN(a)-DOSE trial is a multicenter, randomized, double-blind, placebo-controlled dose-finding Phase 2 study in 281 patients with ASCVD and Lp(a) >150 nmol/L.
The OCEAN(a)-DOSE trial is a...
08/28/2023
Cath Lab Digest
News
08/28/2023

Mount Sinai Health System News

Mount Sinai Health System News ...
As a newer technique, OCT is used in only 3 percent of PCI cases, partly because of a lack of study data—something this new trial aims to change.
As a newer technique, OCT is used in only 3 percent of PCI cases, partly because of a lack of study data—something this new trial aims to change.
As a newer technique, OCT is...
08/28/2023
Cath Lab Digest

Advertisement

News
08/28/2023

University of Glasgow News

University of Glasgow News
The results show that AI interpreted heart ultrasound images, including those taken with a handheld device, are as effective as using a typical ultrasound machine operated by an expert in measuring the pumping action of the heart.
The results show that AI interpreted heart ultrasound images, including those taken with a handheld device, are as effective as using a typical ultrasound machine operated by an expert in measuring the pumping action of the heart.
The results show that AI...
08/28/2023
Cath Lab Digest

Advertisement